Chemoinformaics analysis of 9BETA-HYDROXY-9-HYDRO-16-DEHYDRO-12-METHOXYIBOGAMINE-18-CARBOXYLIC ACID METHYL ESTER
| Molecular Weight | 384.476 | nRot | 3 |
| Heavy Atom Molecular Weight | 356.252 | nRig | 24 |
| Exact Molecular Weight | 384.205 | nRing | 6 |
| Solubility: LogS | -4.293 | nHRing | 4 |
| Solubility: LogP | 2.16 | No. of Aliphatic Rings | 5 |
| Acid Count | 0 | No. of Aromatic Rings | 1 |
| Base Count | 1 | No. of Aliphatic Carbocycles Rings | 1 |
| Atoms Count | 56 | No. of Aliphatic Hetero Cycles | 4 |
| No. of Heavy Atom | 28 | No. of Aromatic Carbocycles | 1 |
| nHetero | 6 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 4 | No. Saturated Carbocycles | 1 |
| No. of Hydrogen atom | 28 | No. of Saturated Hetero Cycles | 3 |
| No. of Carbon atom | 22 | No. of Saturated Rings | 4 |
| No. of Nitrogen atom | 2 | No. of Arom Atom | 6 |
| No. of Oxygen atom | 4 | No. of Arom Bond | 6 |
| nHA | 6 | APOL | 60.8182 |
| nHD | 1 | BPOL | 35.2798 |
| QED | 0.812 |
| Synth | 5.554 |
| Natural Product Likeliness | 1.982 |
| NR-PPAR-gamma | 0.005 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Accepted |
| Pgp-inh | 0.442 |
| Pgp-sub | 0.103 |
| HIA | 0.021 |
| CACO-2 | -4.849 |
| MDCK | 0.0000248 |
| BBB | 0.891 |
| PPB | 0.672519 |
| VDSS | 2.878 |
| FU | 0.241827 |
| CYP1A2-inh | 0.043 |
| CYP1A2-sub | 0.89 |
| CYP2c19-inh | 0.254 |
| CYP2c19-sub | 0.939 |
| CYP2c9-inh | 0.153 |
| CYP2c9-sub | 0.24 |
| CYP2d6-inh | 0.713 |
| CYP2d6-sub | 0.909 |
| CYP3a4-inh | 0.637 |
| CYP3a4-sub | 0.904 |
| CL | 7.704 |
| T12 | 0.123 |
| hERG | 0.022 |
| Ames | 0.335 |
| ROA | 0.926 |
| SkinSen | 0.032 |
| Carcinogencity | 0.957 |
| EI | 0.011 |
| Respiratory | 0.945 |
| NR-Aromatase | 0.851 |
| Antiviral | No |
| Prediction | 0.635626 |